U.S. liver transplants declining

U.S. liver transplants declining
Some livers available for transplant are discarded because they're not healthy enough, study finds.

(HealthDay) -- The number of liver transplants in the United States has decreased since 2006, a new study finds.

Researchers said one reason for the decline is that harvesting livers after cardiac death has become more commonplace, and many of those livers end up being discarded after doctors determine the organs aren't healthy enough to attempt a transplant. Another reason livers are discarded is because of damage due to a condition known as , which is associated with and .

Researchers analyzed data from the United Network for Organ Sharing to assess factors that prompted doctors to discard a donated .

With standard donation, a patient is declared brain dead and kept on cardiovascular support so the organs continue to receive oxygen and blood until they are removed for transplant.

In recent years, there has been increasing use of donor organs after cardiac death. In these cases, organs are harvested for transplant after a patient dies and the heart stops on its own. This type of organ donation is promoted as a way to increase the total number of organs available for transplant, and now accounts for 12 percent of organ donations, compared with fewer than 2 percent less than 10 years ago.

Doctors are becoming increasingly reluctant to use organs donated after cardiac death, however, according to the study, which is scheduled to be presented Tuesday at the meeting in San Diego.

The researchers found that the total number of donors who have at least one organ recovered for transplant has stopped increasing over the past few years, despite an increasing proportion of organs donated after cardiac death.

" donation is negatively impacting the overall number of that we can do," study leader Dr. Eric Orman, a gastroenterology fellow at the University of North Carolina in Chapel Hill, said in a meeting news release.

He and his colleagues also found that donor characteristics associated with a condition called fatty liver -- including diabetes, obesity, old age and high blood pressure -- all were associated with discarding a donated liver.

Because this study was presented at a medical meeting, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

More information: The American Liver Foundation has more about liver transplantation.

add to favorites email to friend print save as pdf

Related Stories

Changes to distribution of livers for transplant proposed

Sep 09, 2011

Transplantation specialists have proposed changes to the allocation and distribution of organs used for liver transplants. The recommended policy modifications take into account the scarcity of available organs, ensuring ...

Rare 'domino' transplant preformed

Oct 03, 2006

U.S. transplant surgeons have performed a "domino" transplant procedure to save two patients suffering a life-threatening liver condition.

Could HIV-infected organs save lives?

Mar 30, 2011

If Congress reversed its ban on allowing people with HIV to be organ donors after their death, roughly 500 HIV-positive patients with kidney or liver failure each year could get transplants within months, rather than the ...

Recommended for you

Hormonal therapy for transsexualism safe and effective

Jun 18, 2013

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

Jun 18, 2013

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...